Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

Genzyme, a Sanofi Company

Overview

This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Osteoarthritis, Knee

Interventions

HylastanDEVICE

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with OA of the knee * Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications Exclusion Criteria: * Prior or concomitant treatments that would impede measurement of safety and efficacy

Locations (24)

Outcomes

Primary Outcomes

pain relief

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.